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Abstract Adipocyte differentiation is a complex process in
which the expression of many transcription factors and
adipocyte-specific genes is regulated under a strict program.
The peroxisome proliferator-activated receptor Q (PPARQ), a
member of the steroid/thyroid nuclear hormone receptor super-
family of ligand-activated transcription factors, is an important
regulator of adipocyte gene expression and differentiation. In
this study, we tried to identify downstream target genes of
PPARQ, by using PPARQ-expressing cells and a subtractive
cloning strategy, and isolated cDNA clones which were up-
regulated or down-regulated by PPARQ. Northern blot analyses
revealed that the expression levels of the aldehyde dehydrogen-
ase-2-like, type VI collagen alpha 3 subunit, cellular retinoic acid
binding protein 1 and thrombospondin 1 are changed during the
differentiation of mouse 3T3-L1 preadipocyte cells, indicating
that these genes might be downstream targets of PPARQ in
adipocyte differentiation. * 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Obesity is associated with type 2 diabetes mellitus charac-
teristic of insulin (Ins) resistance, and both diseases are serious
health problems in developed countries. Obesity results from
an imbalance between energy intake and energy expenditure,
and this imbalance leads to a pathologic accumulation of
adipose tissue. Adipocyte di¡erentiation is a complex process
in which the expression of many transcription factors and
adipocyte-speci¢c genes is programmatically regulated. Evi-
dence is accumulating that three families of transcription fac-
tors, peroxisome proliferator-activated receptor Q (PPARQ),
CCAAT/enhancer-binding proteins and sterol regulatory ele-
ment-binding protein-1, are important regulators for the dif-
ferentiation of preadipocytes into adipocytes [1^3].
PPARQ is a member of the steroid/thyroid nuclear hormone
receptor superfamily of ligand-activated transcription factors.
PPARQ forms a heterodimer with the retinoid X receptor K
and binds to common consensus response elements called
PPAR response elements (PPREs) consisting of a direct repeat
of two hexanucleotides spaced by one nucleotide (DR1, 5P-
AGGTCA A AGGTCA-3P) [4]. PPREs have been reported to
exist in the promoter region of the genes encoding lipoprotein
lipase [5], adipocyte fatty acid binding protein (aP2) [6], phos-
phoenolpyruvate carboxykinase [7] and acylCoA synthase [8].
Ectopic expression of PPARQ in NIH-3T3 ¢broblasts leads to
adipogenic conversion in the presence of its ligands [9,10].
Moreover, loss-of-function experiments using PPARQ3=3
mice or embryonic stem cells have con¢rmed the requirement
of PPARQ for adipogenesis in vivo and in vitro [11^13].
However, the mechanism of adipocyte di¡erentiation
through PPARQ is not fully understood, and the genes regu-
lated by PPARQ remain to be identi¢ed. In this paper, there-
fore, we tried to isolate downstream target genes of PPARQ by
using PPARQ-expressing ¢broblastic cells and a subtractive
cloning strategy.
2. Materials and methods
2.1. Cells and Cell Culture
Mouse NIH-3T3 (clone 5611, JCRB 0615, Japanese Cancer Re-
search Bank) ¢broblasts and mouse 3T3-L1 (ATCC CL173) preadi-
pocytes were maintained in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) containing 10% calf serum (CS). PT-67, a packaging cell
line derived from NIH-3T3 cells (Clontech Lab. Inc., Palo Alto, CA,
USA), was maintained in DMEM containing 10% fetal bovine serum
(FBS).
2.2. Establishment of PPARQ-expressing NIH-3T3 cell lines
A stable transformant expressing PPARQ was established using the
Retro-X System (Clontech Lab. Inc.,) according to the manufacturer’s
instructions, except that pDON-AI (Takara Biomedicals, Kusatsu,
Japan) was used as a retroviral vector. A full-length cDNA encoding
PPARQ derived from PPARQ2/pSVSPORT [6] was inserted into
pDON-AI. The PT-67 packaging cell line was cultured in DMEM
containing 10% FBS and transfected at 80% con£uence by calcium
phosphate coprecipitation [14] with either pDON-AI-PPARQ or empty
pDON-AI. The viruses transiently expressed were harvested 72 h after
transfection and applied to the NIH-3T3 cells in DMEM containing
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10% CS and 4 Wg/ml of polybrene for the infection. The resultant cells
were split 1:4 24 h after infection and replated in DMEM containing
10% CS and 0.5 mg/ml of G418 to eliminate uninfected cells for
10 days.
2.3. Cell culture for induction of di¡erentiation
Following the drug selection, stable virally infected cells were cul-
tured to con£uence in DMEM containing 10% CS and 5 Wg/ml of Ins.
At 2 days after reaching con£uence, the cells were exposed to DMEM
supplemented with 10% FBS, 1 WM dexamethazone (Dex) and 0.5 WM
BRL49653 (5-(4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl)thia-
zolidine-2,4-dione maleic acid salt, a gift from SmithKline Beecham
Pharmaceuticals) for 48 h. After this treatment, the medium was re-
placed with DMEM containing 10% FBS and 0.5 WM BRL49653. At
8 days postinduction, the cells were ¢xed with formalin and stained
with Oil Red O.
For di¡erentiation of 3T3-L1 preadipocytes, 2 day postcon£uent
preadipocytes were cultured with 10 Wg/ml of Ins, 1 WM Dex and
0.5 mM 3-isobutyl-1-methylxanthine (IBMX) in DMEM supple-
mented with 10% FBS. After 48 h, the culture medium was replaced
with DMEM supplemented with 10% FBS and 5 Wg/ml of Ins.
2.4. Subtraction cloning
2 Wg each of Poly (A)þ RNA from untreated NIH-vector cells (a
stable cell line integrated with the pDON-AI vector) or NIH-PPARQ
cells (a stable cell line integrated with pDON-AI-PPARQ) incubated
with inducers described above for 1 day was used for cDNA synthesis.
After RsaI digestion of cDNAs, the cDNA fragments were used for
subtractive hybridization and polymerase chain reaction (PCR) am-
pli¢cation according to the PCR-select cDNA subtraction protocol
(Clontech Lab. Inc.).
The enriched cDNA fragments were digested with RsaI. The resul-
tant fragments were recovered with DE81 paper, subcloned into
EcoRV-digested and dephosphorylated pBluescript KS (+) (Strata-
gene Cloning Systems, La Jolla, CA, USA), and transformed into
DH5K competent cells. The sequences of the inserts were determined
by ABI PRISM 310 (Perkin-Elmer, Applied Biosystems Division,
Foster City, CA, USA).
2.5. RNA isolation and Northern blot analysis
Total RNA was isolated using TRIzol (Gibco BRL Life Technol-
ogies, Gaithersburg, MD, USA). Poly (A)þ RNA was puri¢ed from
total RNA using Oligotex-dT30 (Daiichi Pure Chemicals, Tokyo, Ja-
pan), and used for the subtraction cloning described above. For
Northern blot analysis, 25 Wg of total RNA was electrophoresed on
a 1.0% agarose gel containing 2% formaldehyde, and then transferred
to a Hybond-Nþ nylon membrane (Amersham Pharmacia Biotech
Ltd.). The ¢lter was hybridized with each probe which was labeled
with [K-32P]dCTP using a random labeling kit (Takara Biomedicals).
The ¢lter was washed and then exposed to X-ray ¢lm.
3. Results and discussion
3.1. Establishment of PPARQ-expressing stable transformants
To identify the downstream target genes of PPARQ, we
produced a stable cell line expressing PPARQ. The full-length
cDNA encoding PPARQ was inserted into the retrovirus vec-
tor pDON-AI. This plasmid and the parental expression vec-
tor were transfected into the packaging cell line PT-67, and
the resulting viruses produced were used for infection of NIH-
3T3 cells. The infected cells were then selected by treatment
with the antibiotic, G418. In this manner, stable cell lines were
isolated that contained the parental expression vector (NIH-
vector cells) or expressed PPARQ (NIH-PPARQ cells).
To analyze the expression of the integrated PPARQ gene, we
performed Northern blot analysis using total RNA prepared
from NIH-PPARQ and NIH-vector cells. In both cell lines, the
endogenous expression of PPARQ was not observed. While the
exogenous transcript encoding PPARQ derived from the virus
was produced in NIH-PPARQ cells, NIH-vector cells did not
express the mRNA of exogenous PPARQ (Fig. 1A). To con-
vert these cell lines into adipocytes, the cells were exposed to
DMEM supplemented with FBS, Dex and BRL49653 (high-
a⁄nity ligand for PPARQ) as described under Section 2. As
Fig. 1. Ectopic expression of PPARQ in NIH-3T3 cells and conversion to adipocytes. A: NIH-3T3 cells were infected with retroviruses carrying
pDON-AI or pDON-AI-PPARQ. Total RNA (25 Wg per lane) was isolated from NIH-vector cells and NIH-PPARQ cells, blotted to nylon mem-
brane, and hybridized with 32P-labeled PPARQ or L-actin cDNA. The arrowhead shows the mRNA band derived from the exogenous expres-
sion of PPARQ. B: Stable transformants of NIH-vector and NIH-PPARQ cells were cultured in di¡erentiation medium. At day 8 postinduction,
the cells were ¢xed and stained with Oil Red O.
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shown in Fig. 1B, 50^60% of the NIH-PPARQ cells were
stained with Oil Red O, indicating the storage of droplets of
oil, but no lipid-containing cells were seen among the NIH-
vector cells. When cultured in the di¡erentiation medium
without Dex or BRL49653, NIH-PPARQ cells could not dif-
ferentiate into adipocytes (data not shown).
3.2. Subtraction cloning for isolation of downstream target
genes of PPARQ
By using the stable transformant expressing PPARQ which
gains the potential to di¡erentiate into adipocytes, we next
isolated the genes up-regulated or down-regulated in this sta-
ble transformant in the presence of the inducers. For the for-
ward subtraction (for the isolation of up-regulated genes), the
tester cDNAs were prepared from NIH-PPARQ cells incu-
bated with inducers (FBS, Dex and BRL49653) for 1 day,
and the driver cDNAs were prepared from untreated NIH-
vector cells. For the reverse subtraction (for the isolation of
down-regulated genes), the tester cDNAs were prepared from
untreated NIH-vector cells and the driver cDNAs were pre-
pared from NIH-PPARQ cells incubated with inducers (FBS,
Dex and BRL49653) for 1 day. Accordingly, the forward-sub-
tracted cDNAs contain genes whose expression is increased in
the NIH-PPARQ cells, and the reverse-subtracted cDNAs con-
tain genes whose expression is decreased in the untreated
NIH-vector cells.
For checking the enrichment e⁄ciencies of di¡erentially ex-
pressed genes, we performed PCR analyses using the aP2 gene
which is known to be a target of PPARQ [6] and the glycer-
aldehyde-3-phosphate dehydrogenase (G3PDH) gene which is
a housekeeping gene and expressed constitutively. As shown
in Fig. 2, the fragment of aP2 was concentrated after the
forward subtraction, but not the reverse subtraction. On the
other hand, the expression of G3PDH was not detected after
either the forward or reverse subtraction, indicating that the
subtraction e⁄ciencies were high.
Using this method, we isolated the subtracted cDNAs and
subcloned then. However, unfortunately, it is well known that
many false positive clones are obtained by this protocol.
Therefore, we next performed Northern blot analyses for
the isolated clones, and the results are shown in Fig. 3. Out
of 98 clones isolated from the forward subtraction, 17 clones
were identi¢ed as genes up-regulated, and 10 clones out of 75
clones were identi¢ed as genes down-regulated during the dif-
ferentiation of NIH-PPARQ cells. These clones were se-
quenced and their names are listed in Fig. 3. Finally, we
identi¢ed 10 of 17 forward-subtracted clones as known genes.
Fig. 2. Subtraction e⁄ciency for cloning of di¡erentially expressed
genes. For checking the e⁄ciencies of the forward and reverse sub-
traction, PCR was performed using primers for aP2 and G3PDH,
and subtracted (S) and unsubtracted (U) PCR products were com-
pared.
Fig. 3. Northern blot analyses of up-regulated or down-regulated genes by the addition of di¡erentiation inducers to the PPARQ-expressing
cells. Forward-subtracted (A) and reverse-subtracted (B) clones are shown. Total RNA was isolated from untreated NIH-vector cells (left lane)
and NIH-PPARQ cells treated with di¡erentiation inducers for 1 day (right lane), and 25 Wg of the RNA was analyzed by Northern blotting.
The ¢lter was hybridized with each probe. The sequences of isolated clones were run through DNA databases, and names are shown when
identical to mouse clones. If the clones showed high similarity to other species, the name of the source and the similarity value are shown in
parentheses.
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Seven clones remain as unknown genes that were not in the
database. We also identi¢ed 8 of 10 reverse-subtracted clones
as known genes and two as unknown genes.
3.3. Expression pattern of isolated genes during adipocyte
di¡erentiation of 3T3-L1 cells
3T3-L1 preadipocyte cells, which are ¢broblastic cells des-
tined to become adipocytes, are widely used to investigate the
mechanisms of adipocyte di¡erentiation [15]. When treated
with inducers including Ins, Dex, IBMX and FBS, they under-
go di¡erentiation into mature fat cells over a 6^8 day period.
Since PPARQ is expressed during adipogenesis and plays a key
role in this process, we examined the time course of the ex-
pression of the subtracted genes and also of PPARQ during
adipocyte di¡erentiation. We showed that the expression of
PPARQ started to elevate at 2 days, and that the expression
level of some of these genes changed during the di¡erentiation
process (Fig. 4).
Aldehyde dehydrogenase-2-like (Ahd-2-like) mRNA in-
creased during the di¡erentiation, and this induction coin-
cided with that of a well-known target of PPARQ, aP2. The
type VI collagen alpha 3 subunit (K3 (VI) collagen) was also
increased at 4 days, but decreased at 8 days. K3 (VI) collagen
had already been identi¢ed as a product whose gene is di¡er-
entially expressed during adipocyte development [16].
Unexpectedly, although a cellular retinoic acid binding pro-
tein 1 (CRABP-1) cDNA clone was isolated by reverse sub-
traction, the expression of this clone was elevated relatively
late compared with Ahd-2-like. When Dex was added to NIH-
PPARQ cells, CRABP-I mRNA expression markedly de-
creased, but this clone was induced to express when Dex
was omitted from the medium at 2 days postinduction (data
not shown). Therefore, CRABP-I mRNA might be increased
during 3T3-L1 adipocyte di¡erentiation regardless of the re-
verse subtracted clone. CRABP-I is a member of the gene
superfamily that encodes small proteins involved in the bind-
ing, transport, and metabolism of hydrophobic ligands [17].
Since retinoic acid is known to inhibit the adipocyte di¡er-
entiation [18], it is possible that CRABP-1 has some function-
al role in the conversion to adipocytes. This possibility re-
mains to be tested.
The expression of thrombospondin 1 (TSP1) decreased at
2 days and then markedly increased at 6 days. TSP1 is a large,
trimeric, multidomain extracellular matrix molecule, which is
intimately involved in cell proliferation, cell attachment and
neurite outgrowth [19,20].
In this study, we newly isolated genes using PPARQ-express-
ing cells and a PCR-mediated subtraction protocol. The re-
sults strongly suggest that Ahd-2-like, K3 (VI) collagen,
CRABP-I and TSP1 are the downstream targets of PPARQ
in adipocyte di¡erentiation. Further study including promoter
analyses, is necessary to clarify whether the genes for these
four targets are directly regulated by the transcription factor,
PPARQ.
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